RAMIN MOUSAVI
CEO
CATHWORKS
WHY: Leads Irvine-based developer of the FFRangio system, which provides x-ray imaging of the coronary artery branch and applies machine learning to help doctors identify coronary issues in a noninvasive manner.
IN THE NEWS: Won EU approval in May.
NOTABLE: In 2022, received $75M investment from Medtronic, one of the world’s largest medical device makers. Deal marks biggest investment to date for CathWorks. Agreement provides Medtronic option to buy CathWorks in next five years at a $585M valuation. Business Journal’s 2022 Excellence in Entrepreneurship Award winner.
QUOTABLE: “This approval is perfectly timed for the full European launch of our co-promotion partnership with Medtronic.”
